About one third of American children are overweight or obese. ----- All Pediatric Trials of Sensipar Shut Down Following Patient Death U.S. health officials said Tuesday that they have halted all clinical trials testing the use of the drug Sensipar in children following the death of a teen patient in one of the trials. The anesthesiologist assistant salary U.S. Food and Drug Administration said in a statement that it has not concluded whether the drug, made by Amgen Inc., played a role in the 14-year-old's death. The agency has approved the use of Sensipar to treat an overactive parathyroid gland, which can lead to brittle bones, kidney stones and abdominal pain.visit http://www.healthline.com/healthday/health-highlights-feb for original article for this topic.
Monday, September 9, 2013
Health Highlights: Feb. 26, 2013
About one third of American children are overweight or obese. ----- All Pediatric Trials of Sensipar Shut Down Following Patient Death U.S. health officials said Tuesday that they have halted all clinical trials testing the use of the drug Sensipar in children following the death of a teen patient in one of the trials. The anesthesiologist assistant salary U.S. Food and Drug Administration said in a statement that it has not concluded whether the drug, made by Amgen Inc., played a role in the 14-year-old's death. The agency has approved the use of Sensipar to treat an overactive parathyroid gland, which can lead to brittle bones, kidney stones and abdominal pain.visit http://www.healthline.com/healthday/health-highlights-feb for original article for this topic.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment